Since hepatosplenomegaly and splenomegaly are the most commonly observed clinical syndrome of NPB and higher incidence of neuronopathy with rapid progressive psychomotor deterioration are reported in NPA, we mainly focused on the expression patterns of SMPD1 in the brain, liver, and spleen. This evidence concerns the gene SMPD1 and Splenomegaly.